122 related articles for article (PubMed ID: 9186836)
1. Significance of tumor vascularity as a predictor of long-term prognosis in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection therapy.
Toyoda H; Kumuda T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y
J Hepatol; 1997 May; 26(5):1055-62. PubMed ID: 9186836
[TBL] [Abstract][Full Text] [Related]
2. [The usefulness of percutaneous ethanol injection therapy under guidance with carbon dioxide contrast enhanced ultrasound sonography].
Takeshima K; Kumada T; Kimura T; Nakano S
Nihon Rinsho; 1998 Apr; 56(4):1001-6. PubMed ID: 9577624
[TBL] [Abstract][Full Text] [Related]
3. Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Fukuda H
Kurume Med J; 1998; 45(2):187-93. PubMed ID: 9715046
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma.
Tanikawa K; Majima Y
Hepatogastroenterology; 1993 Aug; 40(4):324-7. PubMed ID: 8406300
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
6. Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma.
Fiore F; Vallone P; Ricchi P; Tambaro R; Daniele B; Sandomenico F; De Vivo R; Civiletti C; Izzo F; Pignata S; Ziviello M
J Clin Gastroenterol; 2000 Sep; 31(2):164-8. PubMed ID: 10993437
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
Ohnishi K; Yoshioka H; Ito S; Fujiwara K
Hepatology; 1998 Jan; 27(1):67-72. PubMed ID: 9425919
[TBL] [Abstract][Full Text] [Related]
8. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles.
Kudo M; Tomita S; Tochio H; Mimura J; Okabe Y; Kashida H; Hirasa M; Ibuki Y; Todo A
Radiology; 1992 Jan; 182(1):155-60. PubMed ID: 1309216
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
[TBL] [Abstract][Full Text] [Related]
10. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.
Lencioni R; Bartolozzi C; Caramella D; Paolicchi A; Carrai M; Maltinti G; Capria A; Tafi A; Conte PF; Bevilacqua G
Cancer; 1995 Nov; 76(10):1737-46. PubMed ID: 8625042
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
Cancer; 1996 May; 77(9):1792-6. PubMed ID: 8646676
[TBL] [Abstract][Full Text] [Related]
13. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial carbon dioxide-enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection therapy.
Chen RC; Wang CK; Chiang LC; Lo HY; Duh SJ; Chen WT; Tu HY; Liao LY; Wang CS; Chen PH
J Gastroenterol Hepatol; 1998 Jan; 13(1):41-6. PubMed ID: 9737570
[TBL] [Abstract][Full Text] [Related]
16. m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma.
Silva MF; Carrilho FJ; Paranaguá-Vezozzo DC; Campos LT; Nacif LS; Diniz MA; Farias AQ; Alves VA; D'Alburquerque LA; Ono SK
Ann Hepatol; 2014; 13(6):796-802. PubMed ID: 25332266
[TBL] [Abstract][Full Text] [Related]
17. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.
Sato S; Shiratori Y; Imamura M; Teratani T; Obi S; Koike Y; Imai Y; Yoshida H; Shiina S; Omata M
J Hepatol; 2001 Aug; 35(2):225-34. PubMed ID: 11580145
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy.
Teratani T; Ishikawa T; Shiratori Y; Shiina S; Yoshida H; Imamura M; Obi S; Sato S; Hamamura K; Omata M
Cancer; 2002 Aug; 95(4):816-23. PubMed ID: 12209726
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC).
Mueller PR
Jpn J Cancer Res; 1995 Nov; 86(11):inside front cover. PubMed ID: 8567388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
